A patient with sickle cell disease is admitted with signs of acute chest syndrome. Which of the following nursing interventions is the highest priority to prevent further respiratory compromise?

A) Administer supplemental oxygen to maintain adequate oxygen saturation

B) Encourage increased oral fluid intake to reduce blood viscosity

C) Administer prescribed analgesics to manage pain

D) Monitor vital signs every 4 hours to detect changes early

A patient with sickle cell disease is admitted with significant anemia, jaundice, and mild pulmonary infiltrates suggestive of early acute chest syndrome. The arterial blood gas analysis shows mild respiratory acidosis and hypoxemia. What is the priority nursing intervention for this patient?

A) Initiate high-flow oxygen therapy to improve oxygenation.

B) Administer a blood transfusion to correct anemia.

C) Encourage ambulation to prevent deep vein thrombosis.

D) Provide a high-calorie, high-protein diet to support recovery.

A patient with sickle cell disease is experiencing acute chest syndrome with symptoms including respiratory distress, increased heart rate, and decreased hemoglobin levels. Which nursing intervention is the most critical to prioritize at this time?

B) Initiate supplemental oxygen therapy to improve oxygen saturation.

A) Administer ordered pain medication to manage discomfort.

B) Initiate supplemental oxygen therapy to improve oxygen saturation.

C) Begin intravenous fluids to ensure adequate hydration.

D) Educate the patient on the importance of hydroxyurea therapy.

A patient with acute chest syndrome is experiencing worsening respiratory distress and anemia. Which nursing intervention should be prioritized to address the patient's current condition?

B) Initiate supplemental oxygen therapy to improve the patient's oxygen saturation.

A) Administer the prescribed antibiotic therapy to treat the potential infection.

B) Initiate supplemental oxygen therapy to improve the patient's oxygen saturation.

C) Prepare for a blood transfusion to address the patient's low hemoglobin levels.

D) Encourage the patient to perform incentive spirometry to prevent atelectasis.

A patient with sickle cell disease experiencing a vaso-occlusive crisis is now exhibiting signs of acute kidney injury with oliguria. Which nursing intervention is most appropriate to prevent further renal damage?

C) Initiate intravenous fluid therapy to maintain adequate hydration

A) Restrict fluid intake to prevent fluid overload

B) Administer diuretics to increase urine output

C) Initiate intravenous fluid therapy to maintain adequate hydration

D) Encourage high-protein diet to support kidney function

A patient with sickle cell disease has developed acute kidney injury (AKI) and is experiencing an increase in generalized body pain. Considering these new complications, which nursing intervention is most critical to prioritize in the management of this patient?

B) Initiating intravenous fluids cautiously to improve renal perfusion

A) Administering prescribed antibiotics promptly to treat potential infection

B) Initiating intravenous fluids cautiously to improve renal perfusion

C) Educating the patient about the benefits of hydroxyurea therapy

D) Adjusting the patient's analgesic regimen to include a PCA pump for pain control

A patient with sickle cell disease presents with new-onset hypertension, proteinuria, and an elevated reticulocyte count. Which of the following interventions should the nurse prioritize to address the patient's current condition?

B) Administer an angiotensin-converting enzyme (ACE) inhibitor as prescribed to protect renal function.

A) Increase fluid intake to manage dehydration and prevent sickle cell crisis.

B) Administer an angiotensin-converting enzyme (ACE) inhibitor as prescribed to protect renal function.

C) Apply warm compresses to painful areas to alleviate vaso-occlusive pain.

D) Initiate oxygen therapy to manage hypoxia and reduce stress on the body.

A patient with sickle cell disease and renal involvement is experiencing elevated blood pressure despite ongoing management. Which clinical intervention is most appropriate to address both the hypertension and renal protection in this scenario?

C) Administer an angiotensin-converting enzyme (ACE) inhibitor.

A) Increase the fluid intake to promote renal perfusion.

B) Initiate a beta-blocker to manage the blood pressure.

C) Administer an angiotensin-converting enzyme (ACE) inhibitor.

D) Implement a diuretic to manage fluid overload.

A patient with sickle cell disease is experiencing splenic sequestration and has received a partial exchange transfusion. Which assessment finding would indicate that the intervention has been effective?

A) Increased hemoglobin level and decreased reticulocyte count

B) Decreased oxygen saturation below 90%

C) Elevated blood pressure requiring further antihypertensive medication

D) Development of acute chest syndrome symptoms

A patient with sickle cell disease is undergoing a partial exchange transfusion due to splenic sequestration. The nurse is monitoring the patient's vital signs and laboratory values. Which of the following findings should be reported immediately to the healthcare provider?

C) Sudden onset of confusion and slurred speech

B) Blood pressure of 140/90 mmHg

C) Sudden onset of confusion and slurred speech

Sickle cell disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Sickle cell disease results from a genetic mutation in the β-globin gene, leading to the formation of abnormal hemoglobin S (HbS). When deoxygenated, HbS polymerizes, causing red blood cells to deform into a sickle shape, which impairs their ability to traverse small blood vessels.

• Secondary mechanism: The sickled red blood cells are prone to hemolysis and have a significantly reduced lifespan, causing chronic hemolytic anemia. This leads to increased bilirubin levels and can cause gallstones and jaundice.

• Key complication: Vaso-occlusive crises occur when sickled cells obstruct blood flow in microcirculation, resulting in ischemia and severe pain. Repeated episodes can cause organ damage, particularly in the spleen, liver, and kidneys, leading to complications like acute chest syndrome and increased risk of infection.

Patient Profile

Demographics:

25-year-old female, high school teacher

History:

• Key past medical history: Sickle cell disease diagnosed at age 2, previous hospitalizations for vaso-occlusive crises, history of acute chest syndrome

• Current medications: Hydroxyurea, folic acid, pain management regimen with NSAIDs and occasional opioids, prophylactic penicillin

• Allergies: Penicillin (rash)

Current Presentation:

• Chief complaint: Increasing frequency of painful crises and fatigue

• Key symptoms: Joint and bone pain primarily in arms and legs, dyspnea on exertion, episodes of dizziness, mild jaundice

• Vital signs: Blood pressure 130/85 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F (37.3°C), oxygen saturation 92% on room air

Section 1

New Diagnostic Results:

Upon admission to the hospital for further evaluation of her symptoms, the patient underwent a series of diagnostic tests to assess the extent of her current condition. A complete blood count revealed a hemoglobin level of 7.2 g/dL, indicating significant anemia, consistent with her history of sickle cell disease. The reticulocyte count was elevated at 8%, reflecting ongoing hemolysis and the bone marrow's attempt to compensate for the anemia. Lactate dehydrogenase (LDH) was also markedly elevated, further supporting the presence of hemolytic activity. Liver function tests showed a mild elevation in bilirubin levels, correlating with her clinical jaundice.

A chest X-ray was performed due to her reported dyspnea and revealed mild pulmonary infiltrates, raising concerns for early acute chest syndrome, a known complication of sickle cell disease. Given her history, this finding necessitated immediate attention to prevent further respiratory compromise. An arterial blood gas analysis showed a mild respiratory acidosis with a pH of 7.32, pCO2 of 48 mmHg, and pO2 of 68 mmHg, confirming impaired gas exchange and hypoxemia.

The patient's laboratory and imaging results highlight the need for a multidisciplinary approach to manage her condition. The team must consider augmenting her current pain management strategy, optimizing hydration and oxygenation, and closely monitoring for signs of progression to more severe complications. These findings also suggest the potential need for a transfusion and further exploration of chronic management strategies, such as regular transfusion therapy or more intensive disease-modifying treatments, to prevent recurrent crises and preserve organ function. As the team deliberates on the next steps, the focus will be on stabilizing her current status while planning long-term interventions to improve her quality of life and reduce the frequency of crises.

Section 2

Change in Patient Status

Over the next 24 hours, the patient's condition began to show signs of deterioration. Despite initial interventions aimed at improving her oxygenation and managing her pain, she developed increasing respiratory distress. Her respiratory rate elevated to 28 breaths per minute, and her oxygen saturation dropped to 85% on room air, prompting the need for supplemental oxygen. On reassessment, coarse crackles were auscultated bilaterally in the lower lung fields, suggesting worsening pulmonary involvement. Additionally, her heart rate climbed to 120 beats per minute, and she reported feeling more fatigued and short of breath with minimal exertion.

Laboratory results indicated a further decrease in hemoglobin to 6.8 g/dL, exacerbating her anemia and contributing to her symptoms. The patient's white blood cell count increased to 15,000 cells/mm^3, hinting at a possible infectious process or inflammation associated with acute chest syndrome. Her LDH levels remained elevated, and bilirubin levels inched higher, reinforcing the ongoing hemolytic activity.

In response to these concerning changes, the clinical team initiated a more aggressive management plan. A decision was made to transfuse packed red blood cells to improve oxygen-carrying capacity and stabilize her hemoglobin levels. Antibiotic therapy was also started empirically to address any potential infectious component of her acute chest syndrome. These steps, coupled with continuous monitoring and supportive care, were crucial to prevent further complications and guide her recovery. The team began discussions on potential long-term strategies, such as hydroxyurea therapy, to prevent future crises and reduce the risk of similar complications.

Section 3

New Complications

Despite the aggressive interventions implemented, the patient began to exhibit signs of a new complication, namely acute kidney injury (AKI). Over the next 12 hours, her urine output decreased significantly, dropping to less than 400 mL per day, indicating oliguria. Blood urea nitrogen (BUN) and creatinine levels were noted to be elevated at 28 mg/dL and 2.1 mg/dL, respectively, signifying impaired renal function. These changes suggested that the hypoxic stress and hemolysis were now impacting her renal system, potentially due to sickling in the renal microvasculature leading to ischemia.

Simultaneously, the patient reported an increase in generalized body pain, which was not entirely responsive to the analgesics previously administered. This increase in pain, coupled with the renal impairment, prompted the clinical team to suspect an ongoing vaso-occlusive crisis exacerbating her condition. The elevated inflammatory markers and a persistently high white blood cell count reinforced the presence of a systemic inflammatory response, possibly linked to a secondary infection or further tissue ischemia.

In light of these developments, the clinical team re-evaluated her management plan. They adjusted her analgesic regimen to include a PCA (patient-controlled analgesia) pump for more effective pain control and initiated intravenous fluids to address the AKI, ensuring meticulous monitoring of her fluid status to avoid fluid overload. Nephrology was consulted to assist in managing her renal function decline. Discussions regarding the potential initiation of hydroxyurea therapy were prioritized, considering its role in reducing sickling episodes and improving overall outcomes. The focus remained on stabilizing her current condition while implementing strategies to prevent further deterioration and address the systemic implications of her sickle cell disease.

Section 4

In the hours following the initiation of the revised management plan, the patient's condition showed some signs of stabilization, but new diagnostic results revealed additional concerns. A repeat complete blood count indicated a drop in hemoglobin levels to 7.5 g/dL, suggesting ongoing hemolysis or possible bleeding. Platelet levels remained stable, but the reticulocyte count was elevated, pointing towards a compensatory response to anemia. The clinical team suspected that the persistent hypoxia and stress on the body were further exacerbating the hemolytic process, potentially due to microvascular occlusions that are common in sickle cell crises.

A urinalysis conducted alongside these labs showed proteinuria and the presence of red blood cell casts, further indicating renal involvement and suggesting a possible glomerular injury. Given these findings, nephrology recommended the addition of an angiotensin-converting enzyme (ACE) inhibitor to help manage the proteinuria and protect renal function. The team also considered the risk of developing chronic kidney disease, prompting the inclusion of renal protective strategies in the long-term management plan.

Despite aggressive fluid management and adjustments to her pain control, the patient’s blood pressure began to rise, with readings consistently around 150/95 mmHg. This hypertension, coupled with her renal impairment, highlighted the delicate balance required in managing her fluid status and cardiovascular health. As her care team worked to optimize her treatment, the patient’s elevated blood pressure necessitated closer cardiovascular monitoring and potential pharmacologic intervention to prevent further complications. The unfolding situation underscored the need for vigilant assessment and a multifaceted approach to address the interconnected challenges posed by her sickle cell disease.

Section 5

As the clinical team continued to monitor the patient's response to the revised management plan, a new set of diagnostic results highlighted an emerging complication. Repeat imaging studies, including a Doppler ultrasound, revealed signs of splenic sequestration, a condition where sickled cells become trapped in the spleen, leading to splenomegaly and a precipitous drop in circulating blood volume. This finding was concerning, given the patient's already low hemoglobin level of 7.5 g/dL and her elevated reticulocyte count, which was now at 10%. The team recognized that the splenic sequestration was contributing to her anemia and required immediate intervention to prevent further hemodynamic instability.

In response to this development, the patient's care plan was adjusted to include a partial exchange transfusion. This procedure aimed to reduce the proportion of sickled cells in her circulation, alleviate the burden on her spleen, and improve her oxygen-carrying capacity. Concurrently, the team increased her oxygen supplementation to address persistent hypoxia, maintaining her oxygen saturation above 92%. Additionally, the patient's blood pressure remained elevated, with readings now reaching 160/100 mmHg, prompting the introduction of a beta-blocker to manage her hypertension and reduce cardiovascular strain.

As the interventions were initiated, the clinical team maintained vigilant monitoring for signs of further complications, such as acute chest syndrome or stroke, both of which are significant risks in sickle cell crisis exacerbated by splenic sequestration and hypertension. The patient was closely observed for changes in respiratory status, neurological function, and any signs of worsening anemia. This comprehensive approach underscored the complexity of managing sickle cell disease, highlighting the need for coordinated care and timely adjustments to her treatment plan as new challenges arose.